Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)

NCT03833362 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Narlaprevir
DRUG: Ritonavir
DRUG: Placebo Narlaprevir
DRUG: Placebo Ritonavir
DRUG: Pegylated interferon alfa-2a/ Pegylated interferon alfa-2b
DRUG: Ribavirin

Sponsor

R-Pharm